Biomerica INC (BMRA) — 10-K Filings
All 10-K filings from Biomerica INC. Browse 2 Annual Report reports with AI-powered summaries and risk analysis.
10-K Filings (2)
-
Biomerica Shifts to Commercialization, Cuts R&D Amid Sales Dip
— Aug 29, 2025 Risk: high
BIOMERICA INC (BMRA) reported a slight decrease in net sales to $5,311,000 for the fiscal year ended May 31, 2025, down from $5,415,000 in fiscal year 2024. The -
Biomerica Inc. Files 2024 10-K
— Aug 28, 2024 Risk: medium
Biomerica Inc. filed its 10-K for the fiscal year ending May 31, 2024, reporting on its operations in the in vitro and in vivo diagnostic substances sector. The
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX